Categories Covid-19 冠病19 News 新闻报道 辉瑞-BioNTech 已完成5到11岁儿童初步临床实验 Post author By imguohao Post date September 29, 2021 No Comments on 辉瑞-BioNTech 已完成5到11岁儿童初步临床实验 (图 / cottonbro) 美国制药公司辉瑞和德国生物科技公司BioNTech,已完成了他们针对5到11岁儿童的初步临床实验,并将会在接下来几个星期内,向美国监管机构,申请紧急授权使用。 辉瑞和BioNTech共同研发的2019冠状病毒疾病疫苗,已在超过两千两百多名5岁到11岁的儿童展开相关的初步临床实验。 如果获得紧急授权使用,5到11岁的相关幼童,最快可能在下个月底,就能接种辉瑞-BioNTech的冠病疫苗。 Advertisement ← 马国新增11,332起冠病确诊病例 → 缅甸军方未来5个月 暂停军事行动 Leave a Reply Cancel reply Enter your comment here... Fill in your details below or click an icon to log in: Email (required) (Address never made public) Name (required) Website You are commenting using your WordPress.com account. ( Log Out / Change ) You are commenting using your Twitter account. ( Log Out / Change ) You are commenting using your Facebook account. ( Log Out / Change ) Cancel Connecting to %s Notify me of new comments via email. Notify me of new posts via email. Δ